<DOC>
	<DOC>NCT00464334</DOC>
	<brief_summary>The purpose of this study is to test the safety, tolerability and the immune response to an investigational vaccine, V950, with or without ISCOMATRIXâ„¢ (IMX).</brief_summary>
	<brief_title>A Study of V950 in People With Alzheimer Disease (V950-001 AM7)</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Patient has mild to moderate Alzheimer Disease Women cannot be able to get pregnant Patient has a reliable caregiver, who will attend all visits and answer questions about the patient Patient lives in a nursing home or facility Patient has another neurological or neurodegenerative disorder Patient has a history of stroke Patient uses illicit drugs or has a history of drug/alcohol abuse Patient has received blood or blood derived products within 6 months</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>